Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI)

CAPS Rating: 1 out of 5

The Company is engaged in developing, implementing and licensing scientific technology for the curing of tobacco and also manufactures, markets and develops very low-nitrosamine smokeless tobacco products and selling of discount cigarettes.

Recs

1
Player Avatar Joytotheinvstmnt (< 20) Submitted: 12/6/2012 4:04:28 PM : Outperform Start Price: $3.11 RCPI Score: -140.55

I have been using Anatabloc personally since January 2012 for treatment of my asthma, which was getting so bad, my Advair 500 was no longer providing relief, & Ventlolin 200 was next to useless. I have now not required Ventolin for months & have cut back to Advair 250, which I am considering ceasing altogether. I can't say how well it treats any other conditions, but it is worth every cent just for its asthma treatment.

Featured Broker Partners


Advertisement